FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients 롱

Amgen Inc.NASDAQ

설명

⋅ 2018년 12월 17일 오후 5시 30분

AMGN: Amgen
2018-12-14 16:00:00
FDA Approves Nplate® (Romiplostim) For Use In Pediatric Patients With Immune Thrombocytopenia